Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDFT1 | P37268 | 16/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8621486 | 0.84 | FDFT1 (0.52) | FDFT1 | |
| SCHEMBL8623415 | 0.82 | FDFT1 (0.63) | FDFT1 | |
| SCHEMBL8623270 | 0.82 | FDFT1 (0.69) | FDFT1 | |
| SCHEMBL1237398 | 0.82 | FDFT1 (0.69) | FDFT1 | |
| SCHEMBL417999 | 0.81 | FDFT1 (0.68) | FDFT1 | |
| Potassium SCHEMBL418001 | 0.81 | FDFT1 (0.68) | FDFT1 | |
| SCHEMBL412160 | 0.81 | FDFT1 (0.62) | FDFT1 | |
| SCHEMBL8622492 | 0.80 | FDFT1 (0.40) | FDFT1 | |
| SCHEMBL8620138 | 0.80 | FDFT1 (0.56) | FDFT1 | |
| SCHEMBL8619974 | 0.80 | FDFT1 (0.56) | FDFT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5470845-A | Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-11-28 | — | — | US | claimed |
| EP-0595635-A1 | Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors | E.R. Squibb & Sons, Inc. (US) | 1994-05-04 | — | — | EP | claimed |
| US-5567841-A | ANTICHOLESTEROL AGENT | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-10-22 | — | — | US | disclosed |
| US-5470845-A | Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-11-28 | — | — | US | disclosed |
| EP-0595635-A1 | Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors | E.R. Squibb & Sons, Inc. (US) | 1994-05-04 | — | — | EP | disclosed |